SOURCE: Spruce Capital Partners

Spruce Capital Partners

June 24, 2015 08:15 ET

Spruce Capital Partner's Ganesh Kishore Named to Scientific American List of Most Influential People in Biotech

SAN FRANCISCO, CA--(Marketwired - Jun 24, 2015) - Scientific American WorldVIEW named Ganesh Kishore, Managing Partner of Spruce Capital Partners and CEO of the Malaysian Life Sciences Capital Fund, to The WorldVIEW 100, a list of the most influential people in biotech today. The publication, which examines innovation in global biotechnology, was released during a Super Session at the 2015 BIO International Convention in Philadelphia June 18.

The magazine enlisted dozens of industry leaders, who initially nominated nearly 400 candidates. The top 100 vote-getters made the final list. The magazine encouraged the nominators to select living experts currently working in the sector from a range of contributing areas, including industry, academia, public policy, finance, law and beyond. The issue can be downloaded for free at http://www.saworldview.com/

"I appreciate this recognition from my colleagues in the industry who compiled this list and the people at Scientific American WorldVIEW," says Dr. Kishore. "I believe it reflects an acknowledgment of the critical role biotechnology can play in addressing complex problems we face today in industry, energy, agriculture, and the environment, and the potential it has for transforming our economy." 

Dr. Kishore has a record of accomplishments in biotechnology research and development and business. Before co-founding Spruce Capital Partners in 2013, he became CEO of the Malaysian Life Sciences Capital Fund. In 2002, Dr. Kishore joined DuPont as the Chief Technology Officer for its Agriculture and Nutrition Platform and took over the role of Chief Biotechnology Officer for the company in 2005. During his tenure at DuPont, he guided the acquisition of several key technology companies and relationships and bolstered the biotech competence within the company.

Prior to that, he played a pivotal role in the transformation of Monsanto from a chemical company into a life sciences company and led the charge on a series of investments in the genomics technologies within Monsanto. As a Senior Research Biochemist at Monsanto, he was responsible for developing processes for the synthesis of Aspartame, the active ingredient of Nutrasweet and Equal. 

Monsanto named Dr. Kishore a Distinguished Science Fellow, the highest honor bestowed upon scientists who have made outstanding contributions to the company but also the scientific field in general, and Assistant Chief Scientist of the company. While with Monsanto, he won the Queeny Award, a prize given by the company in recognition of his contributions to the development of Roundup Ready technology. In addition to his personal contributions as the leader of Plant Sciences Research at Monsanto, his team developed and commercialized most of the agricultural biotechnology products that are in the market today. He played a pivotal role in the transformation of the chemical company into a life sciences company and led the charge on a series of investments in the genomics technologies within the company. He retired from Monsanto after serving as the president of its Nutrition and Consumer Products division as well as the Chief Biotechnologist.

Dr. Kishore has co-founded three successful companies since 2002. Two of the three entities are now parts of publicly traded companies (Tata/Rallis in India and Evolva in Switzerland). The third business (Mogene LC in USA) serves both as an incubator of new ideas, as well as a provider of genomic services across agriculture, healthcare, and the environment. He serves on the board of three publicly listed entities, five privately held companies and the Advisory Board of Washington University. He is also an advisor to the U.S. Department of Energy's Joint Bioenergy Institute, as well as to multinational companies and Scientific American. Dr. Kishore is regarded as one of the visionary leaders of Biotechnology, linking breakthrough science to market needs. 

He earned a PhD in biochemistry from Indian Institute of Science. He received postdoctoral training in chemistry and biology and also served as a Robert A Welch Fellow at The University of Texas at Austin.

About Spruce Capital Partners
The principals and founders of Spruce Capital Partners, Dr. Ganesh Kishore, Dr. Roger Wyse, and Greg Young, are well known investors and thought leaders in the biogreentech sector. They bring a wealth of experience as investors, advisers, and domain experts in helping entrepreneurs build the next generation of successful biogreentech companies. They formed Spruce Capital Partners not only to manage venture funds, but also to develop new talent for the industry, provide thought leadership, and promote innovation in companies and countries. The principals have worked together for more than 10 years and have shepherded investments across multiple funds and multiple sectors. They are also active in advising, partnering, and shaping the life sciences industry globally and, especially in Malaysia and United States. Spruce Capital Partners is a co-manager of the MLS Capital Fund II. Additional information is available at www.sprucecp.com.

Contact Information

  • Contact
    Daniel Levine
    Levine Media Group
    Email Contact
    (510) 280-5405